Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Zydus Lifesciences Ltd.
NSE: ZYDUSLIFE
|
BSE: 532321
|
ISIN: INE010B01027
|
Industry: Pharmaceuticals
Licensing Agreement
|
Strong Performer, Getting Expensive
1015.8500
2.00
(
0.20
%)
NSE
Sep 08, 2025
13:24 PM
27.78% Gain from 52W Low
Volume:
505.2K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Zydus Lifesciences Ltd.
31 May 2022
Licensing Agreement
1015.85
0.20%
ZYDUS LIFESCIENCES LIMITED
Buy:
Zydus Lifesciences Ltd.
by
Geojit BNP Paribas
Target: 440
Target
Geojit BNP Paribas
Zydus Lifesciences L.. has an
average target
of 1045.33 from 6 brokers.
More from Zydus Lifesciences Ltd.
Recommended
Market trades higher, Vedanta emerges as the highest bidder for Jaiprakash Associates
Trendlyne Marketwatch |
08 Sep 2025, 01:23PM
Five Interesting Stocks Today - September 5, 2025
The Baseline |
05 Sep 2025
Earnings Call Transcript - Cadila Healthcare
|
14 Feb 2020